The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the sector. A shift away from Schedule I status, often viewed as outdated and hindering advancement, https://doctorbookmark.com/story20797507/pot-rescheduling-a-expansion-catalyst